Sarkar Arin G, Sharma Ankur, Kothari Nikhil, Goyal Shilpa, Meshram Tanvi, Kumari Kamlesh, Mohammed Sadik, Bhatia Pradeep
Department of Anesthesiology and Critical Care, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Department of Trauma & Emergency (Anesthesiology and Critical Care), All India Institute of Medical Sciences (AIIMS), Jodhpur, India.
Indian J Crit Care Med. 2024 Sep;28(9):842-846. doi: 10.5005/jp-journals-10071-24792. Epub 2024 Aug 31.
We compared the modified ROX index and ROX index scores in earlier predictions of high-flow nasal oxygen (HFNO) therapy outcomes in patients with acute respiratory failure.
We conducted a prospective observational study on 151 acute respiratory failure patients initiated on HFNO therapy. The primary objective of this research was to compare the modified ROX index and ROX index to investigate which score predicted HFNO treatment outcome earlier.
The modified ROX index score had better predictive power than the ROX score at different time points, especially one hour following the start of HFNO therapy (AUC 0.790; 95% CI: 0.717-0.863; < 0.001). For the ROX Index at 1 hour, the ideal cut-off value for HFNO outcome was 4.36 (sensitivity: 72.6%, specificity: 53.9%), and for the modified ROX index at 1 hour, it was 4.63 (sensitivity: 74.2%, specificity: 69.7%). The presence of various comorbidities didn't show any change in ROX-HR cut-off values.
The modified ROX index is a better predictor of the success of HFNO therapy than the ROX index. Furthermore, the presence of any comorbidities did not affect modified ROX index cut-off values or the outcome of HFNO therapy.
Sarkar AG, Sharma A, Kothari N, Goyal S, Meshram T, Kumari K, . Comparison of Modified ROX Index Score and ROX Index Score for Early Prediction of High Flow Nasal Oxygen Therapy Outcome in Patients with Acute Respiratory Failure: A Prospective Observational Cohort Study. Indian J Crit Care Med 2024;28(9):842-846.
我们比较了改良ROX指数和ROX指数在急性呼吸衰竭患者高流量鼻导管给氧(HFNO)治疗结局早期预测中的得分情况。
我们对151例开始接受HFNO治疗的急性呼吸衰竭患者进行了一项前瞻性观察研究。本研究的主要目的是比较改良ROX指数和ROX指数,以探究哪个得分能更早地预测HFNO治疗结局。
在不同时间点,改良ROX指数得分比ROX得分具有更好的预测能力,尤其是在HFNO治疗开始后1小时(AUC 0.790;95% CI:0.717 - 0.863;P < 0.001)。对于1小时的ROX指数,HFNO治疗结局的理想截断值为4.36(敏感性:72.6%,特异性:53.9%),而对于1小时的改良ROX指数,其理想截断值为4.63(敏感性:74.2%,特异性:69.7%)。各种合并症的存在并未使ROX-HR截断值发生任何变化。
改良ROX指数比ROX指数更能准确预测HFNO治疗的成功与否。此外,任何合并症的存在均未影响改良ROX指数的截断值或HFNO治疗的结局。
Sarkar AG, Sharma A, Kothari N, Goyal S, Meshram T, Kumari K, . 改良ROX指数得分与ROX指数得分在急性呼吸衰竭患者高流量鼻导管给氧治疗结局早期预测中的比较:一项前瞻性观察队列研究。《印度重症监护医学杂志》2024;28(9):842 - 846。